319 related articles for article (PubMed ID: 19487308)
1. Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease.
Freude S; Hettich MM; Schumann C; Stöhr O; Koch L; Köhler C; Udelhoven M; Leeser U; Müller M; Kubota N; Kadowaki T; Krone W; Schröder H; Brüning JC; Schubert M
FASEB J; 2009 Oct; 23(10):3315-24. PubMed ID: 19487308
[TBL] [Abstract][Full Text] [Related]
2. Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease.
Stöhr O; Schilbach K; Moll L; Hettich MM; Freude S; Wunderlich FT; Ernst M; Zemva J; Brüning JC; Krone W; Udelhoven M; Schubert M
Age (Dordr); 2013 Feb; 35(1):83-101. PubMed ID: 22057897
[TBL] [Abstract][Full Text] [Related]
3. Neuron-specific deletion of a single copy of the insulin-like growth factor-1 receptor gene reduces fat accumulation during aging.
Freude S; Schilbach K; Hettich MM; Brönneke HS; Zemva J; Krone W; Schubert M
Horm Metab Res; 2012 Feb; 44(2):99-104. PubMed ID: 22198814
[TBL] [Abstract][Full Text] [Related]
4. The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.
Zemva J; Schubert M
CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):322-37. PubMed ID: 24059318
[TBL] [Abstract][Full Text] [Related]
5. IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination.
Freude S; Leeser U; Müller M; Hettich MM; Udelhoven M; Schilbach K; Tobe K; Kadowaki T; Köhler C; Schröder H; Krone W; Brüning JC; Schubert M
J Neurochem; 2008 Nov; 107(4):907-17. PubMed ID: 18717815
[TBL] [Abstract][Full Text] [Related]
6. Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance.
Gontier G; George C; Chaker Z; Holzenberger M; Aïd S
J Neurosci; 2015 Aug; 35(33):11500-13. PubMed ID: 26290229
[TBL] [Abstract][Full Text] [Related]
7. The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease.
Freude S; Schilbach K; Schubert M
Curr Alzheimer Res; 2009 Jun; 6(3):213-23. PubMed ID: 19519303
[TBL] [Abstract][Full Text] [Related]
8. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling.
Moloney AM; Griffin RJ; Timmons S; O'Connor R; Ravid R; O'Neill C
Neurobiol Aging; 2010 Feb; 31(2):224-43. PubMed ID: 18479783
[TBL] [Abstract][Full Text] [Related]
9. Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice.
Chua LM; Lim ML; Chong PR; Hu ZP; Cheung NS; Wong BS
J Alzheimers Dis; 2012; 29(4):783-91. PubMed ID: 22337827
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
[TBL] [Abstract][Full Text] [Related]
11. Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models.
Zhang B; Tang XC; Zhang HY
J Neurosci Res; 2013 May; 91(5):717-25. PubMed ID: 23401344
[TBL] [Abstract][Full Text] [Related]
12. Involvement of insulin-like growth factor 1 receptor signaling in the amyloid-β peptide oligomers-induced p75 neurotrophin receptor protein expression in mouse hippocampus.
Ito S; Ménard M; Atkinson T; Gaudet C; Brown L; Whitfield J; Chakravarthy B
J Alzheimers Dis; 2012; 31(3):493-506. PubMed ID: 22635104
[TBL] [Abstract][Full Text] [Related]
13. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY
FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638
[TBL] [Abstract][Full Text] [Related]
14. Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease.
O'Neill C; Kiely AP; Coakley MF; Manning S; Long-Smith CM
Biochem Soc Trans; 2012 Aug; 40(4):721-7. PubMed ID: 22817723
[TBL] [Abstract][Full Text] [Related]
15. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
16. Genetic Reduction of Insulin Signaling Mitigates Amyloid-β Deposition by Promoting Expression of Extracellular Matrix Proteins in the Brain.
Sano T; Ochiai T; Nagayama T; Nakamura A; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
J Neurosci; 2023 Oct; 43(43):7226-7241. PubMed ID: 37699718
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?
Carro E; Trejo JL; Spuch C; Bohl D; Heard JM; Torres-Aleman I
Neurobiol Aging; 2006 Nov; 27(11):1618-31. PubMed ID: 16274856
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells.
Tsukamoto E; Hashimoto Y; Kanekura K; Niikura T; Aiso S; Nishimoto I
J Neurosci Res; 2003 Sep; 73(5):627-36. PubMed ID: 12929130
[TBL] [Abstract][Full Text] [Related]
20. Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease.
Christensen DZ; Bayer TA; Wirths O
Neurobiol Aging; 2010 Jul; 31(7):1153-63. PubMed ID: 18771817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
